Dexamethasone/Miconazole/Mupirocin clEARmix Thermo Gel Otic (3mL Syringe)

How to Use clEARmix Thermo Gel Otic (Ear Medication)

This is a liquid ear medication that turns into a gel once it warms up in your pet’s ear, helping it stay in place and work effectively. It comes in a soft-tipped syringe for easy use.

Step-by-Step:

1. Keep it cool – Store in the fridge if instructed. Before using, hold the syringe in your hands for a minute so it’s not too cold, but don’t warm it too much.
2. Get your pet ready – Have them sit comfortably and gently lift the ear flap. A second person can help hold them still if needed.
3. Clean the ear (if advised) – Use a vet-approved ear cleaner and cotton ball. Wipe out any debris and let the ear dry.
4. Apply the medication – Take off the cap. Gently insert just the tip into the ear opening (not deep), and slowly press the plunger to deliver the full dose.
5. Massage the ear – Rub the base of the ear for 30 seconds. The liquid will turn into a gel as it warms, and massaging helps it spread inside the ear.
6. Let them shake it out – It’s normal! Wipe away any extra gel you see near the ear opening.
7. Reward your pet – Offer praise or a treat to keep the experience positive.
8. Store and clean up – Recap the syringe and refrigerate if needed. Wash your hands afterward.

This compounded formulation combines active ingredients from different drug classes: dexamethasone, a corticosteroid; miconazole, an azole antifungal; and mupirocin, a topical antibiotic. In compounding practice, clinicians may consider a multi-ingredient preparation like this to address more than one aspect of a patient's physiology at once. Your veterinarian determines whether it is appropriate based on your animal's diagnostic findings.

At a pharmacological level, dexamethasone acts as a synthetic glucocorticoid that modulates the inflammatory response by binding to intracellular receptors and managing the production of inflammatory mediators. This mechanism manages the localized swelling, redness and itching associated with tissue irritation. Miconazole is an imidazole antifungal agent that acts by inhibiting the synthesis of ergosterol, a component of fungal cell membranes. By managing the structural integrity of the fungal cell, the medication provides a method for managing yeast populations.

Mupirocin is an antibacterial agent characterized by its unique mechanism of inhibiting bacterial protein synthesis. It acts by binding to the enzyme isoleucyl-tRNA synthetase, which provides a method for managing susceptible bacteria, including certain resistant strains that may not respond to other antibiotic classes. By delivering these three agents in a single topical application, your veterinarian can manage the complex microbial flora of the skin while reducing the inflammatory components of the disease. Your veterinarian will determine the clinical appropriateness of this combination based on diagnostic findings such as cytology, culture and sensitivity results or a physical examination.

This description reflects the general pharmacology of the active ingredient's drug class; your veterinarian determines whether this approach is appropriate for your animal.

Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.

Commonly observed effects following the administration of this combination include localized changes at the application site, such as mild redness, discharge or temporary irritation. Because the formulation contains dexamethasone, systemic absorption is possible with prolonged use; your veterinarian will monitor for observational signs of corticosteroid influence, such as increased thirst, increased urination or changes in appetite.

A high-priority clinical consideration before administering any otic medication is ensuring the eardrum (tympanic membrane) is intact. If the medication passes into the middle or inner ear, it may lead to inner ear sensitivity, changes in balance or hearing loss. Owners should monitor their pet for behavioral shifts including a head tilt, loss of balance or sudden changes in hearing and contact their veterinarian promptly with any concerns regarding the patient's response to the medication.

This medication is typically used with extra caution or avoided in patients with a known hypersensitivity to imidazoles, mupirocin or corticosteroids. Significant interactions can occur if this medication is administered concurrently with other topical agents or specific systemic prescriptions that influence the immune system. Your veterinarian is the right person to provide guidance on the necessary frequency of use and the most appropriate monitoring schedule to ensure the management approach remains suitable for your pet's individual recovery.